CEO SUMMARY: On July 7, CMS imposed severe sanctions on Theranos for CLIA violations. Included is a two-year ban on owning and operating a clinical laboratory for Theranos, CEO Elizabeth Holmes, the former COO, and the former medical director. Theranos appears to be pivoting away from a clinical lab testing business strategy and back to […]
Theranos Now Scrambling To Save What It Can
In a first after 13 years, lab will have experienced executives handling regulatory compliance, quality
- By Joseph Burns
- > From the Volume XXIII No. 10 - July 25, 2016 Issue
- Tags: analyzer, analyzers, cap, clia, clia certificate, clia inspection, clia lab, clia license, clinical lab, clinical lab services, clinical lab test, clinical lab testing, Clinical Laboratory, clinical laboratory improvement amendments, Clinical Laboratory Improvement Amendments of 1988 (CLIA), clinical laboratory industry, clinical laboratory test, clinical laboratory testing, clinical laboratory tests, cms clia, dark report, diagnostic testing, Elizabeth Holmes, FDA Clearance, health care information technology, hematology, hie, lab industry, lab service, lab services, lab test, lab test prices, lab testing, laboratories, laboratory industry, laboratory service, laboratory services, laboratory test, laboratory testing, laboratory tests, medical compliance, Medicare, Medicare Part B, quality system, quality systems, the dark report, the laboratory, Theranos
